Conversely, initial studies comparing tirzepatide vs retatrutide have shown that retatrutide has demonstrated even more promising outcomes, with participants losing an average of 24.2% of their body mass after 48 weeks
Moreover, the expression of key spermatogenesis markers, including UCHL1, PLZF, SCP3, and PCNA, which were reduced in aged testes, were significantly restored or increased following FOXO4-DRI treatment
In addition, the groups wants to study whether or not certain HFpEF patients may benefit more than others
However, these trials excluded patients with personal or family histories of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2), because animal studies at high doses showed thyroid C-cell tumors
However, the results may vary based on individual factors such as adherence to the program, starting weight, and overall lifestyle changes
65 AbenavoliLScarpelliniEColicaCBoccutoLSalehiBSharifi-RadJet al
